Shandong Xinhua Pharmaceutical (00719.HK) reported a net profit attributable to shareholders of RMB 195 million for the first three quarters, down 23.88% year on year.

Zhitong Finance APP News, Shandong Xinhua Pharmaceutical (00719.HK) announced its results for the nine months ended September 30, 2026, with operating revenue of RMB 6.061 billion (the same below), a year-on-year decrease of 10.38%; net profit attributable to shareholders of the listed company of RMB 195 million, a year-on-year decrease of 23.88%; basic earnings per share of RMB 0.28.